APP下载

介入治疗在原发性肝癌中的应用

2015-03-11辛晟梁

中国当代医药 2015年2期
关键词:原发性肝癌介入治疗

辛晟梁

[摘要] 原发性肝癌在我国属于高发病率、高死亡率的恶性肿瘤,由于其早期症状不突出且无特异性,因此一旦发病,预后很差。原发性肝癌具有特殊的血供方式,1978年日本Yamada教授首次提出了经导管动脉化疗栓塞治疗肝脏肿瘤的设想并实践成功,至此介入治疗成为原发性肝癌的又一种治疗方法。随着新思想、新技术、新材料的不断涌现,介入治疗的优势越来越明显,逐渐成为治疗原发性肝癌的主要方法,甚至是常规方法之一。

[关键词] 原发性肝癌;介入治疗;经导管动脉化疗栓塞

[中图分类号] R735.7 [文献标识码] A [文章编号] 1674-4721(2015)01(b)-0010-05

Application of interventional therapy in primary hepatocellular carcinoma

XIN Sheng-liang

The Second Clinical Medical College of Shanxi Medical University,Taiyuan 030001,China

[Abstract] Primary hepatocellular carcinoma(PHC) is the tumor with high incidence and mortality in our country.For absence of characteristic and differential manifestations in early stage,the prognoses always indicate pessimistic outcomes unexpected once patients feel sick.Primary hepatocellular carcinoma has a special blood supply,in 1978,Japanese professor Yamada first initiated one idea called transcatheter arterial chemoembolization(TACE) which is based on the spcial perfusion of PHC and performed it successfully.From then on,TACE becomes another effective choice to patients with PHC.With new thoughts,new technologies,new materials arising,interventional therapy plays significant roles in such field increasingly.Now,interventional therapy has been a principal treatment to PHC,even employed regularly.

[Key words] Primary hepatocellular carcinoma;Interventional therapy;Transcatheter arterial chemoembolization

原发性肝癌(primary hepatocellular carcinoma,PHC)是世界上最常见的六大恶性肿瘤之一,同时其致死率高居恶性肿瘤的第三位[1]。世界上每年大约有70万人死于原发性肝癌,男性发病率往往会更高,男女患者比例可达2∶1,甚至是4∶1[2]。我国原发性肝癌患者及死亡人数均占全球的50%以上[3]。目前为止,外科手术依然是原发性肝癌的首选治疗方法[2]。然而,我国的原发性肝癌有其自身特点,即起病隐匿、发展迅速,且多数具有肝炎-肝硬化背景,患者一旦出现较为明显的临床症状则往往提示病情已经进展至中、晚期,失去了宝贵的手术机会。

介入放射学(interventional radiology)是在影像设备的引导下,利用经皮穿刺或体表自然孔道路径,引入导管、导丝、球囊导管、支架等相关器材对疾病进行微创诊断与治疗的新型亚学科,其中经导管动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)是介入治疗的突出代表,原发性肝癌则是各种介入治疗手段应用最广、技术最成熟且疗效最确切的恶性肿瘤[4]。……

登录APP查看全文

猜你喜欢

原发性肝癌介入治疗
三维适形半野轮照放疗技术治疗局部晚期原发性肝癌的临床疗效
心血管介入治疗后拔管反应的临床研究
高频彩色多普勒超声引导下髋部滑囊炎的介入治疗探讨
消癌平片联合TACE术治疗老年原发性肝癌的疗效和生命质量的临床观察
气道肿瘤所致气管狭窄经支气管镜介入治疗的临床疗效观察
贝伐单抗联合肝动脉化疗栓塞术对36例晚期原发性肝癌生存预后的影响分析
急性心肌梗死患者经皮冠状动脉介入和静脉溶栓治疗后心率变异性的影响研究
急性冠脉综合征患者介入治疗中替罗非班的应用及意义探究
探讨氯吡格雷预防冠心病介入治疗心血管的临床疗效
TACE序贯3D—CRT治疗原发性肝癌的疗效及安全性观察